insulin novo nordisk - Search News

FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

Hosted on MSN · 11h

Novo’s Ozempic Shortage Is Declared Over, Hitting Copycats

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications.

STAT · 16h

Novo Nordisk shortage of Ozempic and Wegovy ends, threatening compounders

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies of Ozempic and Wegovy.

1hon MSN

Why Novo Nordisk A/S (NVO) Surged On Friday?

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...

25d

Novo Nordisk to cap insulin prices in Minnesota settlement; joins Lilly, Sanofi

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest insulin makers of charging astronomically high prices for the diabetes ...

Novo Nordisk Prices In Too Few New Patients For GLP-1 Currently

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

pharmaphorum2y

Novo Nordisk achieve headline results with icodec insulin

Novo Nordisk’s ONWARDS program for once-weekly insulin icodec comprises six phase 3a global clinical trials, including a trial with RWE involving more than 4,000 adults with type 1 or type 2 ...

FiercePharma16h

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Why Novo Nordisk Is A Strong Buy Despite Market Concerns

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

5don MSN

2 Important Insights From Novo Nordisk's Earnings Call

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results